Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Neha Mehta‐Shah"'
Autor:
Vikas R. Dharnidharka, MD, MPH, Kristine M. Wylie, PhD, Todd N. Wylie, BS, Marianna B. Ruzinova, MD, PhD, Charles W. Goss, PhD, Gregory A. Storch, MD, Neha Mehta-Shah, MD, Derek Byers, MD, Leslie Walther, RN, Lujain Jaza, MD, Hongjie Gu, MS, Mansi Agarwal, PhD, MPH, Michael Green, MD, MPH, Erika Moore, MD, Steven H. Swerdlow, MD, Fernanda Silveira, MD, Lianna J. Marks, MD, Dita Gratzinger, MD, Adam Bagg, MD, Soi Cheng Law, PhD, Maher Gandhi, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 11, p e1723 (2024)
Post-transplant lymphoproliferative disorders (PTLDs) remain a feared complication of transplantation, with significant morbidity and mortality. The oncogenic Epstein-Barr virus (EBV) is a key pathogenic driver in 50%–80% of cases. Numerous prognos
Externí odkaz:
https://doaj.org/article/428e9dfd237045e18df0376bfbfc2718
Autor:
Carine M. Lama, MS, Miguel A. Hernandez-Rovira, BSc, Neha Mehta-Shah, MD, Aaron Russell, MD, Amy C.M. Musiek, MD
Publikováno v:
JAAD Case Reports, Vol 38, Iss , Pp 64-67 (2023)
Externí odkaz:
https://doaj.org/article/dc688cb637f54280ae61160e69871a2d
Autor:
Sneha Poondru, Ancy Joseph, John C. Harding, Hemalatha Sundaramoorthi, Neha Mehta-Shah, Patrick Green, Anjum Hassan, Daniel A. Rauch, Lee Ratner
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 3, Pp 918-926 (2022)
Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retrovirus. Of the approximate ten to twenty million people currently infected worldwide, 4–9% of infected individuals develop adult T-cell leukemia/lymphoma (ATLL) or HTLV-associated myel
Externí odkaz:
https://doaj.org/article/a05422beb4484eab863a0a749fed7c8e
Autor:
Todd A. Fehniger, Marcus P. Watkins, Nkiruka Ezenwajiaku, Fei Wan, David D. Hurd, Amanda F. Cashen, Kristie A. Blum, Andre Goy, Timothy S. Fenske, Nina D. Wagner-Johnston, Kenneth Carson, Marilyn J. Siegel, David Russler-Germain, Stephanie E. Schneider, Neha Mehta-Shah, Brad Kahl, Nancy L. Bartlett
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/efad7cdbfb6a49e8a0a6ae296cdf46cf
Autor:
Neha Mehta-Shah, Eric Jacobsen, Pier Luigi Zinzani, Jasmine Zain, Monica Mead, Carla Casulo, Giuseppi Gritti, Lauren Pinter-Brown, Koji Izutsu, Sheila Waters, Jonathan Brammer, Barbara Pro, Steven Horwitz
Publikováno v:
HemaSphere, Vol 7, p e3891642 (2023)
Externí odkaz:
https://doaj.org/article/7e93c7f4700c401abfd1e0f1f8521b40
Autor:
Austin Jacobsen, Ying Huang, Natalie Hill, Karina Elias, Matthew Holman, Skyler Gordon, Nicole Foley, David Russler-Germain, Marcus Watkins, Eric D. Jacobsen, Alison Moskowitz, Amanda Cashen, Todd A. Fehniger, Brad Kahl, Armin Ghobadi, Beth Reagan, Anne Fischer, Fei Wan, Steven Horwitz, Neha Mehta-Shah
Publikováno v:
HemaSphere, Vol 7, p e01519ba (2023)
Externí odkaz:
https://doaj.org/article/0f6dc17d28ce4214bf4b37802314466d
Autor:
Neel S. Raval, BS, MPHS, Nora A. Alexander, BS, Karlee De Monnin, BS, Christine C. Yokoyama, MD, PhD, Neha Mehta-Shah, MD, Ilana S. Rosman, MD, Amy C. Musiek, MD
Publikováno v:
JAAD Case Reports, Vol 19, Iss , Pp 68-70 (2022)
Externí odkaz:
https://doaj.org/article/252d5b92f2464a0db1afe6f27679be15
Autor:
Jared M. Andrews, Jennifer A. Schmidt, Kenneth R. Carson, Amy C. Musiek, Neha Mehta-Shah, Jacqueline E. Payton
Publikováno v:
EBioMedicine, Vol 46, Iss , Pp 170-183 (2019)
Background: Treatment for Cutaneous T Cell Lymphoma (CTCL) is generally not curative. Therefore, selecting therapy that is effective and tolerable is critical to clinical decision-making. Histone deacetylase inhibitors (HDACi), epigenetic modifier dr
Externí odkaz:
https://doaj.org/article/aedb9d7ddd2a48bebd9a1e1008a9ce36
Autor:
Julio C. Chavez, Francine M. Foss, Basem M. William, Jonathan E. Brammer, Sonali M. Smith, Anca Prica, Jasmine M. Zain, Joseph M. Tuscano, Harsh Shah, Neha Mehta-Shah, Praveen Ramakrishnan Geethakumari, Ben X. Wang, Stephanie Zantinge, Lisa Wang, Ling Zhang, Anmarie Boutrin, Weiguang Zhao, Lily Cheng, Nathan Standifer, Lisa Hewitt, Enowmpey Enowtambong, Weiping Shao, Shringi Sharma, Gianluca Carlesso, Jeffrey A. Moscow, Lillian L. Siu
Publikováno v:
Clinical Cancer Research. 29:1869-1878
Purpose: Proliferation of T-follicular helper (TFH) CD4+ T cells is a postulated pathogenic mechanism for T-cell non-Hodgkin lymphomas (T-NHL). The inducible T-cell costimulator (ICOS) is highly expressed by TFH, representing a potential target. MEDI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a4cb46e12f0d99a411c75d11ce7c312
https://doi.org/10.1158/1078-0432.ccr-22-2955
https://doi.org/10.1158/1078-0432.ccr-22-2955
Autor:
Rahul S. Bhansali, Fredrik Ellin, Miao Cao, Thomas Relander, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R Hwang, N. Nora Bennani, Julio C. Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine Zain, Miguel Ruiz, Jonathan E Brammer, Rishab Prakash, Swami P. Iyer, Adam J. Olszewski, Ajay Major, Sonali M. Smith, Peter A. Riedell, Caroline Goldin, Bradley M. Haverkos, Bei Hu, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M Goodman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita Dwivedy Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Publikováno v:
Blood. 140:1481-1484
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69b2196b50b3e2a198c4251230b77c07
https://doi.org/10.1182/blood-2022-160090
https://doi.org/10.1182/blood-2022-160090